Amboy Group of Woodbridge, N.J., is recalling an undetermined amount of raw boneless and skinless chicken breasts.

The products may contain milk, egg and soy, allergens not declared on the label.

There have been no confirmed reports of adverse reactions.

The following raw boneless and skinless poultry items, produced from December 5, 2016, through December 5, 2018, are being recalled:

• 16-oz. plastic trays of “Shop Rite Ready To Cook BONELESS & SKINLESS Chicken Breast Italian Style Panko Breaded.”
• 16-oz. plastic trays of “Shop Rite Ready To Cook BONELESS & SKINLESS Chicken Breast Sundried Tomato Panko Breaded.”
• 16-oz. plastic trays of “Shop Rite Ready To Cook BONELESS & SKINLESS Chicken Breast Parmesan Panko Breaded.”
• 16-oz. plastic trays of “Shop Rite Ready To Cook BONELESS & SKINLESS Chicken Breast Mustard Panko Breaded.”

The recalled products, bearing establishment number “EST. P-33789” inside the USDA mark of inspection, were shipped to retail locations in New Jersey.

What to do

Customers who purchased the recalled products should not consume them, but discard them or return them to the place of purchase.

Consumers with questions about the recall may contact Logan McNamara at (732) 682-8329.

Volkswagen Group of America is recalling 5,987 model year 2007-2012 Audi Q7s and model year 2009-2012 Audi Q5s.

These vehicles were previously repaired with an interim repair of installing butyl tape to the fuel pump flange, until replacement remedy parts became available.

The butyl tape may not prevent fuel from leaking. A fuel leak in the presence of an ignition source can increase the risk of a fire.

What to do

Volkswagen will notify owners, and dealers will replace the fuel pump flange and install butyl tape, free of charge.

The recall is expected to begin December 31, 2018.

Owners may contact Audi customer service at (800)-253-2834. Volkswagen's number for this recall is 20BJ.

Pregnancy comes with several health risks, both for mothers and their babies. Though nine months of pregnancy come with countless doctor’s appointments and a keen sense of attention to women’s bodies and overall health, research has shown why that shouldn’t stop after the baby is born.

A new study conducted by researchers from the University of North Carolina Gillings School of Global Public Health found that women could be at risk for developing breast cancer for up to 20 years after childbirth.

“What we saw was this pattern where risk was highest about five years after birth, and then it gradually declined as time went on,” lead researcher Dr. Hazel Nichols told CNN.

Women at risk

The researchers collected data from 15 cohort studies to explore the likelihood of women developing breast cancer post-childbirth. All of the women involved in the study were under the age of 55, and those who had given birth were compared with those of the same age who had not.

For the women who had experienced childbirth, their risk for developing breast cancer was higher than for those who hadn’t. The researchers found that the risk could last for up to 24 years post-birth, but it was at its highest level five years following childbirth.

The risk of developing breast cancer was highest for women who had the disease in their family lines, in addition to women who had children later in life. However, a mother’s decision to breastfeed didn’t affect their risk of developing breast cancer.

The researchers are hopeful that the findings from this study will urge healthcare providers to make the most informed choices for their patients and promote preventive breast cancer measures.

Other breast cancer risks

With nearly one in eight women in the United States at risk of developing invasive breast cancer, it’s important that consumers know some preventive measures associated with the disease.

Last year, researchers found that women that took just 81mg of aspirin on a regular basis were less likely to develop breast cancer. However, that wasn’t the case for women that took a different painkiller or a higher dosage.

The researchers explain that aspirin can work as an aromatase inhibitor, which reduces the amount of estrogen in the blood and can therefore help to reduce the risk of breast cancer.

“We did not by and large find associations with the other pain medications like ibuprofen and acetaminophen,” said Dr. Christina A. Clarke. “We also did not find associations with regular aspirin since this type of medication is taken sporadically for headaches or other pain, and not daily for prevention of cardiovascular disease.”

Researchers also found that for postmenopausal women, losing weight was effective in reducing the risk of breast cancer.

While gaining weight wasn’t found to be a direct link to breast cancer, the study participants that gained weight were over 50 percent more likely to develop triple negative breast cancer -- a strain of the illness that doesn’t respond to traditional hormonal therapy. Conversely, those who lost weight over the course of the study were just 12 percent likely to develop breast cancer.

Skip Hop of New York is recalling about 41,000 Tuo convertible high chairs sold in the U.S. and Canada.

The legs on the highchair can detach from the seat, posing fall and injury hazards to children.

The firm has received 17 reports of the legs of the high chairs detaching. No injuries have been reported.

This recall involves Skip Hop’s Tuo convertible high chairs with charcoal gray or silver/white with clouds fabric.

They have a reversible seat pad, removable tray, 5-point harness, beechwood footrest and legs. The high chairs can be converted into a toddler chair.

One of the following style numbers and corresponding date code can be found on the back of the chair:

The high chairs, manufactured in China, were sold at Babies ”R” Us, Buy Buy Baby, Target, Kohls, Dillards and other children specialty stores nationwide and online at Amazon.com and Skiphop.com from June 2017, through December 2018, for about $160.

What to do

Consumers should immediately stop using the recalled high chairs and contact Skip Hop for a full refund or an e gift card of equal value.

Consumers may contact Skip Hop toll-free at (888) 282-4674 from 9 a.m. to 5 p.m. (ET) Monday through Friday, or online at www.skiphop.com and click on “Product Recalls” at the bottom of the page for more information.

American Honda Motor Co. is recalling 403 model year 2019 Honda Ridgelines and Pilots.

The mounting holes for the clip that secures the right center pillar trim panel may be larger than intended.

In the event of a crash necessitating right side curtain air bag deployment, the clip may not hold the center pillar trim panel in position and it may potentially interfere with the curtain air bag deployment.

If the curtain air bag does not deploy as intended, it can increase the risk of injury.

What to do

Honda will notify owners, and dealers will install a bracket on the right center pillar that will securely hold the center pillar trim clip, free of charge.

The recall is expected to begin January 25, 2019.

Owners may contact Honda customer service at 1-888-234-2138. Honda's number for this recall is D3D.